1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Relevium Technologies Inc.

Relevium Technologies Inc.

RLLVF
Relevium Technologies Inc.US flagOther OTC
0.01
USD
- -
- -
1.98MMarket Cap

Total Valuation

Relevium Technologies Inc. carries a market capitalization of 1.98M, placing it among publicly traded companies globally. Its enterprise value stands at 4.66M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.98M
Enterprise Value4.66M

Share Statistics

Relevium Technologies Inc. currently has 329.49M shares outstanding.

Shares Outstanding329.49M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.27, and the price-to-book ratio stands at -0.65.

PE RatioN/A
PS Ratio0.27
PB Ratio-0.65
P/TBV Ratio-2.21
P/FCF Ratio0.17
P/OCF Ratio0.17

Enterprise Valuation

On an enterprise value basis, Relevium Technologies Inc. trades at an EV/EBITDA multiple of 4.00 and an EV/FCF ratio of 0.21. The EV/Sales ratio of 0.33 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.00 provides insight into valuation relative to core operating earnings.

EV / Sales0.33
EV / EBITDA4.00
EV / EBIT4.00
EV / FCF0.21

Financial Position

Relevium Technologies Inc. maintains a current ratio of 0.59, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -129.43, indicating conservative leverage, while an interest coverage ratio of 1.77 demonstrates limited ability to service its debt obligations.

Current Ratio0.59
Quick Ratio0.56
Debt / Equity-129.43
Debt / EBITDA1.26
Interest Coverage1.77

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-17.50
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)91.18
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover153.67

Stock Price Statistics

Relevium Technologies Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.

Beta (5Y)N/A
52-Week Price Change0%
50-Day Moving Average0.01
200-Day Moving Average0.01
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Relevium Technologies Inc. generated 14.25M in revenue and converted that into -2.64M in net income, yielding earnings per share of -0.01. EBITDA reached 1.17M, while operating income came in at 1.17M.

Revenue14.25M
Gross Profit2.47M
Operating Income1.17M
Pretax Income-2.64M
Net Income-2.64M
EBITDA1.17M
EBIT1.17M
Earnings Per Share (EPS)-0.01

Balance Sheet

Relevium Technologies Inc. holds 586,303.00 in cash and equivalents against 1.47M in total debt, resulting in a net debt position of 891,561.00. Total book value stands at -5.84M, with working capital of -1.67M providing operational flexibility.

Cash & Cash Equivalents586,303.00
Total Debt1.47M
Net Debt891,561.00
Equity (Book Value)-5.84M
Book Value Per Share-0.02
Working Capital-1.67M

Cash Flow

Relevium Technologies Inc. produced 22.05M in operating cash flow over the past twelve months.

Operating Cash Flow22.05M
Capital ExpendituresN/A
Free Cash Flow22.05M
FCF Per Share0.07

Margins

Relevium Technologies Inc. operates with a gross margin of 17.32, reflecting its pricing power and cost economics. The operating margin of 8.18 and net profit margin of -18.50 provide insight into operational efficiency.

Gross Margin17.32
Operating Margin8.18
Pretax Margin-18.50
Profit Margin-18.50
EBITDA Margin8.19

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield620.16
FCF Yield583.59

Scores

Relevium Technologies Inc. posts an Altman Z-Score of -5.72, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-5.72